It seems insulin production and beta cell functioning may persist despite the onset of Type 1 diabetes, according to research conducted at the Massachusetts General Hospital and published in the March issue of Diabetes Care.
New research on a rare genetic disorder in which the pancreas fails to grow could shed light on how the organ develops and lead to treatments for Type 1 diabetes.
A late-stage trial of a biologic treatment for Type 1 diabetes appears to have failed, according to results announced Friday.
Drug maker Eli Lilly and the Juvenile Diabetes Research Foundation will fund research to find ways to regenerate insulin-producing cells in patients with Type 1 diabetes.
In patients with Type 1 diabetes, the islet cells of the pancreas are destroyed, thus eliminating the organ’s ability to produce insulin.
A peptide, along with its receptor, that is released when the body responds to stress...